S. 976 (110th): Genomics and Personalized Medicine Act of 2007

Introduced:
Mar 23, 2007 (110th Congress, 2007–2009)
Sponsor:
Sen. Barack Obama [D-IL]
Status:
Died (Referred to Committee)

The bill’s title was written by the bill’s sponsor. S. stands for Senate bill.

(About Ads | Go Ad-Free for $5)
Status

This bill was introduced on March 23, 2007, in a previous session of Congress, but was not enacted.

Progress
Introduced Mar 23, 2007
Referred to Committee Mar 23, 2007
Cosponsors
2 cosponsors (1R, 1D) (show)
Committees

Senate Health, Education, Labor, and Pensions

The committee chair determines whether a bill will move past the committee stage.

Full Title

A bill to secure the promise of personalized medicine for all Americans by expanding and accelerating genomics research and initiatives to improve the accuracy of disease diagnosis, increase the safety of drugs, and identify novel treatments.

Summary

No summaries available.

Text

Read Bill Text »

Last updated Mar 23, 2007.
32 pages

Primary Source

View on THOMAS (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here.

Citation

Click a format for a citation suggestion:

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

3/23/2007--Introduced.
Genomics and Personalized Medicine Act of 2007 - Directs the Secretary of Health and Human Services to:
(1) establish the Genomics and Personalized Medicine Interagency Working Group (IWG) to facilitate collaboration, coordination, and integration of activities among federal agencies relating to genomic research and initiatives;
(2) establish a national biobanking distributed database for the collection and integration of genomic data and associated environmental and clinical health information;
(3) establish a grant program for academic medical centers and other entities to develop or expand biobanking initiatives;
(4) improve genetics and genomics training for diagnosis, treatment, and counseling of adults and children for both rare and common disorders;
(5) contract with the National Academy of Sciences to study incentives to encourage companion diagnostic test development; and
(6) make information available on the safety and efficacy of genetic tests and commission a study for improving federal oversight and regulation of such tests.
Requires the Director of the Centers for Disease Control and Prevention to:
(1) conduct an analysis of the public health impact of direct-to-consumer marketing of genetic tests; and
(2) expand efforts to educate the public about genomics and its health applications.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

The bill contains the following citations to other parts of U.S. law:

United States Code

The United States Code is the compilation of permanent laws enacted by Congress. Temporary and other non-permanent laws do not appear in the United States Code. (About half of the United States Code is the law itself, called positive law. The other half is merely a compilation of the laws but has no legal significance.)